Caffeine, nicotine and mecamylamine share stimulus properties in the preexposure conditioned taste aversion procedure

• Published in: Psychopharmacologia 2001-12, Vol.159 (1), p.70-76
• Main Authors: KUNIN, Daniel, BLOCH, Richard T, SMITH, Brian R, AMIT, Zalman
• Format: Article
• Language: English
• Subjects: Acetylcholine receptors; Animals; Avoidance Learning - drug effects; Biological and medical sciences; Caffeine; Caffeine - pharmacology; Central Nervous System Stimulants - pharmacology; Cholinergic system; Conditioning (Psychology) - drug effects; Conditioning (Psychology) - physiology; Dose-Response Relationship, Drug; Male; Mecamylamine; Mecamylamine - pharmacology; Medical sciences; Neuropharmacology; Neurotransmitters. Neurotransmission. Receptors; Nicotine; Nicotine - pharmacology; Nicotinic Agonists - pharmacology; Nicotinic Antagonists - pharmacology; Pharmacology. Drug treatments; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Psychotropic drugs; Rats; Rats, Wistar; Taste - drug effects; Taste - physiology; Taste aversion
• ISSN: 0033-3158; 1432-2072
• DOI: 10.1007/s002130100888

The present study examined whether nicotine and caffeine, two of the most widely used psychoactive drugs, share stimulus properties in the preexposure conditioned taste aversion (CTA) procedure. To determine whether nicotine would attenuate the formation of a caffeine-induced CTA and further assess whether pretreatment with mecamylamine, a nicotinic receptor antagonist, would reverse nicotine's attenuating effect of a caffeine-induced CTA. Male Wistar rats were preexposed with one of three doses of nicotine (0.6, 1.2 and 2.0 mg/kg, s.c.) for three consecutive days, then 24 h following the final preexposure injection were conditioned with caffeine (20 mg/kg and 30 mg/kg, i.p.) in a standard two-bottle test. There were four conditioning trials and four drug-free test days. In a follow-up study, rats were pretreated with mecamylamine (2 mg/kg, i.p.) prior to preexposure injections with nicotine (0.6 mg/kg, i.p.), then subsequently conditioned with caffeine (20 mg/kg, i.p.) as described above. The lowest nicotine dose (0.6 mg/kg) attenuated the caffeine induced CTAs (20 mg/kg and 30 mg/kg) but the higher nicotine doses showed no such attenuating effect. In addition, mecamylamine reversed the nicotine-induced attenuation of the caffeine-induced CTA and also directly attenuated it. These results suggested that caffeine, nicotine and mecamylamine share overlapping stimulus properties and that the nature of this relationship may involve action at the nicotinic-cholinergic receptor.